Q BioMed Inc
Change company Symbol lookup
Select an option...
QBIO Q BioMed Inc
PXSAP Pyxis Tankers Inc
DNUT Krispy Kreme Inc
SDGR Schrodinger Inc
BOAS BOA Acquisition Corp
ESBA Empire State Realty OP LP
CMS CMS Energy Corp
POWRU Powered Brands
VLDRW Velodyne Lidar Equity Warrants Exp 29 Sep 2025 *W EXP 09/29/2025

Health Care : Biotechnology |
Company profile

Q BioMed, Inc., incorporated on November 22, 2013, is a biomedical acceleration and development company. The Company focuses on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. Q BioMed acquires assets across healthcare related products, companies and sectors. It has portfolio of five therapeutic products, including Strontium-89 and MetastronTM for metastatic bone cancer pain and three development stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder; Uttroside-B for liver cancer, and MAN 01 for glaucoma. Its MAN platform has therapeutics in development in various indications, including vascular and infectious diseases. The infectious diseases that it can treat includes influenza, COVID-19, Ebola and others. The Company's subsidiaries include Q BioMed Cayman SEZC and QBMG Q BioMed Germany UG.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    3:31p ET 01/27/22
  • Last (size)
  • 52-Wk Range
    0.265 - 1.59
  • (02/10/21 - 12/15/21)
  • 89.2%
  • Market Cap
  • Shares Outstanding
  • -0.40
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 11.10
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.